Delirium attributed to the use of metoprolol;Delirant beeld, toegeschreven aan het gebruik van metoprolol

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 39, 2005, Pages 2183-2186

  Van Der Vleuten, P A ^a   Van Den Brink, E ^a   Schoonderwoerd, B A ^a   Van Den Berg, F ^a   Tio, R A ^a   Zijlstra, F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ATORVASTATIN; HALOPERIDOL; METOPROLOL; QUINAPRIL;

ADULT; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; COLLAPSE; DELIRIUM; DRUG WITHDRAWAL; FOLLOW UP; HEART ATRIUM FLUTTER; HUMAN; LACERATION; LIVER DYSFUNCTION; LIVER ENZYME ELEVATION; MALE; PERSONALITY DISORDER; RIB FRACTURE; SYMPTOM; VISUAL HALLUCINATION;

ADRENERGIC BETA-ANTAGONISTS; ALCOHOLISM; DELIRIUM; HUMANS; LIVER; MALE; METOPROLOL; MIDDLE AGED;

EID: 25444475838     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Olsson G, Tuomilehto J, Berglund G, Elmfeldt D, Warnold I, Barber H, et al. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study. Am J Hypertens 1991;4(2 Pt 1):151-8.
2. Kendall MJ. Clinical trial data on the cardioprotective effects of beta-blockade. Basic Res Cardiol 2000;95 Suppl 1:125-30.
3. Skinner C, Gaddie J, Palmer KN. Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction. Br Med J 1976; 1(6008):504.
4. Cruickshank JM. The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 1980;100:160-78.
5. Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med 1989;149:514-25.
6. Gengo FM, Gabos C. Central nervous system considerations in the use of beta-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension. Am Heart J 1988;116(1 Pt 2):305-10.
7. Mast RC van der, Huyse FJ, Rosier PFWM. Rjchtlijn 'Delirium'. Ned Tijdschr Geneeskd 2005;149:1027-33.
8. Gleiter CH, Deckert J. Adverse CNS-effects of beta-adrenoceptor blockers. Pharmacopsychiatry 1996;29:201-11.
9. McAinsh J, Cruickshank JM. Beta-blockers and central nervous system side effects. Pharmacol Ther 1990;46:163-97.
10. Fisher AA, Davis M, Jeffery I. Acute delirium induced by metoprolol. Cardiovasc Drugs Ther 2002;16:161-5.
11. Parker DL, Hodge JR. Delirium in a coronary care unit. JAMA 1967; 201:702-3.
12. Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987;221:155-8.
13. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand 1988;223:525-30.
14. Conway J, Greenwood DT, Middlemiss DN. Central nervous actions of beta-adrenoreceptor antagonists. Clin Sci Mol Med 1978;54: 119-24.
15. Turner P. Beta-adrenoceptor blockers reduce blood pressure in normal subjects. Br J Clin Pharmacol 1983;15:128.
16. Drayer DE. Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers. Pharmacotherapy 1987;7:87-91.
17. McCaffrey PM, Riddell JG, Shanks RG. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. Br J Clin Pharmacol 1987;24:571-80.
18. Hickey PL, McLean AJ, Angus PW, Choo EF, Morgan DJ. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. Gastroenterology 1996;111: 1039-48.
19. Le Couteur DG, McLean AJ. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998;34: 359-73.